Edges in Network
| Network | GSE16446_top8000 - GSE16446 - SiGN-BN NNSR |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | HLA-DMA |
| Upstream (Parents) |
|---|
| (<<) HLA-DRB6 → HLA-DMA |
| (<<) HLA-DOA → HLA-DMA |
| (<<) HLA-DRB1 → HLA-DMA |
| (<<) CD53 → HLA-DMA |
| Downstream (Children) |
|---|
| HLA-DMA → TNFSF12-TNFSF13///TNFSF12///TNFSF13 (>>) |
| HLA-DMA → HLA-DRB6 (>>) |
| HLA-DMA → PCDHGA4 (>>) |
| HLA-DMA → HLA-DOA (>>) |
| HLA-DMA → HLA-DMB (>>) |
| HLA-DMA → HLA-DRB1 (>>) |
| HLA-DMA → LST1 (>>) |
| HLA-DMA → IL18BP (>>) |
| HLA-DMA → LCP1 (>>) |
| HLA-DMA → ARHGAP26 (>>) |
| HLA-DMA → CSF2RA (>>) |
